Aurinia Pharmaceuticals (AUPH) Income from Continuing Operations (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Income from Continuing Operations of $37.39 million for Q2 2026, up 73.8% from $21.51 million a year earlier and up 8.9% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aurinia Pharmaceuticals' Income from Continuing Operations came in at $314.1 million, up 418.0% year-over-year; for FY2025, it was $287.2 million.
- By year, Income from Continuing Operations came in at $5.75 million in FY2024, -$78.02 million in FY2023, -$108.18 million in FY2022 and -$180.97 million in FY2021.
- Five-year quarterly Income from Continuing Operations spans a low of -$50.26 million in Q3 2021 and a high of $210.84 million in Q4 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.33 million (Q1 2026), $210.84 million (Q4 2025) and $31.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Aurinia Pharmaceuticals | 2.15 Bn | 580.05 Mn | 76.67 Mn | 37.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.39 Mn |
| Mar 31, 2026 | 34.33 Mn |
| Dec 31, 2025 | 210.84 Mn |
| Sep 30, 2025 | 31.55 Mn |
| Jun 30, 2025 | 21.51 Mn |
| Mar 31, 2025 | 23.34 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 14.31 Mn |
| Jun 30, 2024 | 678,000.00 |
| Mar 31, 2024 | -10.75 Mn |
| Dec 31, 2023 | -26.87 Mn |
| Sep 30, 2023 | -13.45 Mn |
| Jun 30, 2023 | -11.49 Mn |
| Mar 31, 2023 | -26.21 Mn |
| Dec 31, 2022 | -26.05 Mn |
| Sep 30, 2022 | -8.99 Mn |
| Jun 30, 2022 | -35.52 Mn |
| Mar 31, 2022 | -37.63 Mn |
| Dec 31, 2021 | -33.32 Mn |
| Sep 30, 2021 | -50.26 Mn |
API Access
Aurinia Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();